Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain



Status:Recruiting
Conditions:Back Pain, Back Pain, Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:11/1/2018
Start Date:October 25, 2018
End Date:September 2023
Contact:Gert Bronfort, PhD, DC
Email:bronf003@umn.edu
Phone:612-301-9006

Use our guide to learn which trials are right for you!

Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back

The long-term objective is to reduce overall low back pain (LBP) burden by testing scalable,
first-line, non-pharmacologic strategies that address the biopsychosocial aspects of
acute/sub-acute LBP and prevent transition to chronic back pain.

The US is in the midst of an unprecedented pain management crisis. LBP is the most common
chronic pain condition in adults and the leading cause of disability worldwide. Guidelines
have recommended non-pharmacologic treatments like spinal manipulation and behavioral
approaches for LBP for nearly a decade, yet uptake and adherence has been poor. Moreover,
little is known about the role of these treatments in the secondary prevention of chronic LBP
(cLBP), especially for patients with biopsychosocial risk factors. With burgeoning costs,
mounting evidence of ineffectiveness, and harms of commonly used drug treatments, including
opioids, there is a critical need for research on non-pharmacological treatments for cLBP
prevention that can be readily translated to practice.


Inclusion Criteria:

- At least 18 years of age

- Acute or sub-acute low back pain

- Average low back pain severity ≥3 on the 0-10 numerical rating scale over 7 days

- Medium or high risk for persistent disabling back pain according to the STarT Back
screening tool

- Ability to read and write fluently in English

Exclusion Criteria:

- Non-mechanical causes of low back pain

- Contraindications to study treatments (e.g,. surgical fusion of lumbar spine)

- Active management of current episode of low back pain by another healthcare provider

- Serious co-morbid health condition that either requires medical attention or has a
risk for general health decline over the next year

- Pregnancy, current or planned during study period and nursing mothers

- Inability or unwillingness to give written informed consent
We found this trial at
3
sites
Seattle, Washington 98104
(206) 543-2100
Principal Investigator: Patrick Heagerty, PhD, MS
Phone: 206-543-1882
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: Gert Bronfort, PhD, DC
Phone: 612-301-9009
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
(412) 624-4141
Principal Investigator: Michael Schneider, PhD, DC
Phone: 412-383-4323
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials